BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36744385)

  • 1. The diagnostic significance of CDH17-positive circulating tumor cells in patients with colorectal cancer.
    Pei XM; Wong HT; Ng SSM; Leung WW; Wong YN; Tsang HF; Chan AKC; Wong YKE; Yu ACS; Yim AKY; Cho WCS; Chan JKC; Wong KF; Luk JM; Tai WCS; Wong SCC
    Expert Rev Mol Diagn; 2023 Feb; 23(2):171-179. PubMed ID: 36744385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients.
    Kaifi JT; Kunkel M; Zhu J; Dicker DT; Gusani N; Yang Z; Sarwani NE; Li G; Kimchi ET; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2013 Dec; 14(12):1174-81. PubMed ID: 24153154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
    Hou J; Guo C; Lyu G
    Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
    Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
    Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis.
    He Y; He X; Zhou Y; Luo S
    BMC Cancer; 2023 Jul; 23(1):707. PubMed ID: 37507669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
    Abdalla TSA; Meiners J; Riethdorf S; König A; Melling N; Gorges T; Karstens KF; Izbicki JR; Pantel K; Reeh M
    PLoS One; 2021; 16(6):e0252897. PubMed ID: 34111181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
    Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility.
    Petrik J; Verbanac D; Fabijanec M; Hulina-Tomašković A; Čeri A; Somborac-Bačura A; Petlevski R; Grdić Rajković M; Rumora L; Krušlin B; Štefanović M; Ljubičić N; Baršić N; Hanžek A; Bočkor L; Ćelap I; Demirović A; Barišić K
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
    Lu G; Lu Z; Li C; Huang X; Luo Q
    Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
    Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.
    Onstenk W; Sieuwerts AM; Mostert B; Lalmahomed Z; Bolt-de Vries JB; van Galen A; Smid M; Kraan J; Van M; de Weerd V; Ramírez-Moreno R; Biermann K; Verhoef C; Grünhagen DJ; IJzermans JN; Gratama JW; Martens JW; Foekens JA; Sleijfer S
    Oncotarget; 2016 Sep; 7(37):59058-59069. PubMed ID: 27340863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
    Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
    Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
    Steinert G; Schölch S; Koch M; Weitz J
    Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.